GM ITD Products for 10,000+
Targets / Biomarkers of Multiple Species
Example: PD1, LAG3, TIGIT, CLDN, Tau, Abeta
Lenti/AAV/AdV-ORF plasmid and particle
GeneMedi TarMart: Solution for potential therapeutics targets and diagnostics biomarkers
TarMart™ is GeneMedi's all-in-one industry solution for therapeutic targets and diagnostics biomarkers. It leverages the robust capabilities of the GM-ITD database to provide an expansive portfolio of product solutions, encompassing a diverse array of target classes. These offerings are tailored to support the intricate processes of drug discovery and development, facilitate the discovery of diagnostic biomarkers, and foster the advancement of fundamental research in the field of biology.
Our product lines include:
Checkpoint-Immuno Oncology Epigenetic G protein-coupled receptors (GPCR) Ion Channel
Nuclear Receptors Kinase Pathway Assays Tumor-associated antigen (TAA)
Our expansive product portfolio has been designed to meet the highest quality standards and is validated using rigorous testing procedures.
GeneMedi provides benchmark antibodies for ELISA, affinity binding assays, drug discovery, and mechanism of action (MOA) research applications.
Q1. What types of products does GeneMedi offer for drug
discovery and development research?
A1: GeneMedi offers a wide range of products for drug discovery and development research, such as Checkpoint, Epigenetic, GPCR, Ion Channel, Kinase, Nuclear Receptors, Pathway Assays, and Tumor-associated antigen (TAA).
Q2. What quality standards do GeneMedi's products meet?
A2: GeneMedi's products meet the highest quality standards and are rigorously tested to ensure reliability and reproducibility.
Q3. What is GeneMedi ITD?
A3: GeneMedi ITD is a target-insight database that connects human indications/diseases/conditions with associated targets/biomarkers in diagnostics, therapeutics, and prognostics using AI-based data analysis.
Q4. How does GeneMedi ITD help improve the efficiency of industry solutions?
A4: GeneMedi ITD identifies key insights and relationships within complex datasets using closed-loop design and AI-based data analysis, enabling more efficient and effective drug development and diagnostic solutions.
Q5. What research areas are supported by GeneMedi's diverse product offerings?
A5: GeneMedi's diverse product offerings support various research areas, including drug discovery and development research across different targets such as Checkpoint, Epigenetic, GPCR, Ion Channel, Kinase, Nuclear Receptors, Pathway Assays, and Tumor-associated antigen (TAA).
Empowered by GM-ITD database, TarMart™ is GM's all-in-one industry solution for therapeutic targets and diagnostics biomarkers.
GM-ITD, the GeneMedi Insight-target database, serves as a comprehensive platform that seamlessly connects human indications, diseases, and conditions with their corresponding targets and biomarkers in the realms of diagnostics, therapeutics, and prognostics.
We develop solutions for
the therapeutics and diagnostics industry.